MedWorld Advisors Completes Record Year Amid MedTech M&A Surge
Deal News | Jan 08, 2025 | EIN
In 2024, MedWorld Advisors reached a milestone by setting a new record in MedTech M&A transactions, concluding the year with over $200 million in enterprise value sold across five deals on three continents. As global demand for innovation in healthcare continues to rise, the firm's CEO, Florence Joffroy-Black, anticipates that the favorable merger environment will persist into 2025. MedWorld Advisors will leverage this success by attending the JPMorgan Healthcare Conference to pursue further opportunities in the healthcare sector.
Sectors
- Healthcare
- Mergers & Acquisitions
Geography
- Global – MedWorld Advisors conducted deals on three continents, showcasing a global reach.
- United States – The firm will attend the JPMorgan Healthcare Conference in San Francisco, emphasizing its activities within the U.S.
Industry
- Healthcare – Relevant due to the focus on MedTech and other healthcare-related mergers and acquisitions.
- Mergers & Acquisitions – Relevant as the article discusses multiple M&A deals completed by MedWorld Advisors.
Financials
- $200 Million – The total enterprise value of sell-side deals closed by MedWorld Advisors in 2024.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| MedWorld Advisors | M&A Advisory Firm | Company | A boutique firm specializing in healthcare-sector mergers and acquisitions. |
| Florence Joffroy-Black | CEO/President | Person | CEO and President of MedWorld Advisors, providing strategic guidance and commentary. |
| Daniel Sheppard | Managing Director | Person | Managing Director at MedWorld Advisors, responsible for engaging potential clients at the JPMorgan Healthcare Conference. |